SCHEMBL4158065

SCHEMBL4158065

O=C(Cc1ccccc1)N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NCC(O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.45
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
NPY1R P25929 2/20 0.41
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CHRNA1 P02708 5/20 0.39
CHRNG P07510 5/20 0.39
CHRNB1 P11230 5/20 0.39
CHRND Q07001 5/20 0.39
CNR2 P34972 4/20 0.39
TACR1 P25103 1/20 0.37
CNR1 P21554 1/20 0.37
BCAT2 O15382 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4161122 0.86 NPC1 (0.46) CES1HDAC1HDAC2KMT2A
Trifluoroacetic Acid SCHEMBL4158022 0.85 HDAC1 (0.38) CES1HDAC1HDAC2NPY1RBCAT2
SCHEMBL4606734 0.82 NPY1R (0.46) CES1HDAC1HDAC2NPY1RALDH1A1
SCHEMBL4166891 0.82 CES1 (0.52) CES1HDAC1HDAC2NPY1RCHRNA1
SCHEMBL4159834 0.81 EPHX2 (0.43) HDAC1HDAC2CTSLCTSBCTSS
Trifluoroacetic Acid SCHEMBL4304780 0.80 CES1 (0.50) CES1HDAC1HDAC2NPY1RCNR2
SCHEMBL4620748 0.80 LMNA (0.40) ALDH1A1KMT2A
SCHEMBL4166649 0.80 HDAC1 (0.38) CES1HDAC1HDAC2NPY1RCTSB
SCHEMBL4605614 0.79 CES1 (0.45) CES1HDAC1HDAC2NPY1RCNR2
SCHEMBL4605724 0.78 CES1 (0.46) CES1HDAC1HDAC2NPY1RCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 CES1 1925/4885HDAC1 2/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.